Agios
@AgiosPharma
Passionately committed to applying our leadership in cellular metabolism to transform the lives of people with rare diseases
Women have long been pioneers in STEM – pushing boundaries and shaping the world we know today. This #WomensHistoryMonth, our Women’s Leadership & Inclusion (WL&I) employee resource group is celebrating their impact and sharing stories of the women and allies who are part of WL&I…
We are hosting a conference call and live webcast on Thursday, July 31, at 8:00 a.m. ET to report and discuss our second quarter 2025 financial results and other business highlights. Instructions on how to join the webcast are available here: bit.ly/4nNJm5U

#AgiosNews: Dr. Jay Backstrom has been appointed to our Board of Directors and will serve on the Science and Technology Committee. Read more: bit.ly/4kkJ833


We’re at #EHA2025 (booth # C04), connecting with the #hematology community and our partners to explore the latest research and share the progress of our pyruvate kinase activation portfolio in rare blood disorders. Learn more about our presence at the meeting:…

#AgiosNews: Our Leadership Team will present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 9, at 8:40 a.m. ET. We’ll highlight our 2025 strategic priorities, current progress, and future outlook. Learn more and listen here: bit.ly/3GGeFyj

We’re excited to return to #EHA2025 to connect with the #hematology community and share our clinical results and scientific insights, highlighting the potential of our pyruvate kinase (PK) activation portfolio in treating rare blood disorders. Read more: bit.ly/4j6hYw9
#AgiosNews: This month, our Leadership Team will present at the BofA Securities and RBC Capital Markets 2025 healthcare conferences. We’ll share updates on our 2025 strategic priorities and engage investors in conversations about our long-term vision. Learn more:…

#AgiosNews: Today, we reported our first quarter 2025 financial results, along with recent business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: bit.ly/4jZrsui

We’re fueled by connections – to one another and to the rare disease communities we serve. Read our 2025 ESG report to learn how we engage with the community to develop and deliver innovative medicines, advance research, and foster a purpose-driven culture.…
We are hosting a conference call and live webcast on Thursday, May 1, at 8:00 a.m. ET to report and discuss our first quarter 2025 financial results and other business highlights. Instructions on how to join the webcast are available here: bit.ly/3Gp1oKi

For our last Women’s Leadership & Inclusion (WL&I) Spotlight, we are recognizing Yola Pesha, Associate Director, Analytical Development. Inspired by her mother, a mentor, and her daughter, Yola champions resilience and empowerment. Thank you for joining us in celebrating these…

For this week’s Women’s Leadership & Inclusion (WL&I) Spotlight, we are recognizing Karen Norton, Director, Program Management. Karen is passionate about science, inclusion, and the power of women supporting women. Her advice? Be brave. Try new things. Thrive. Stay tuned next…

For our first Women’s Leadership & Inclusion (WL&I) Spotlight this #WomensHistoryMonth, we are recognizing Parija Patel and Clive Patience – the driving forces behind our WL&I employee resource group. Their leadership has made a meaningful impact on their colleagues and…

#AgiosNews: This week, members of our Leadership Team will attend and present at the Leerink Global Healthcare Conference 2025 and the Barclays 27th Annual Global Healthcare Conference. We will provide key updates on our 2025 strategic priorities and engage investors in…

#InternationalWomensDay honors the achievements of women while highlighting the need for gender equality. This year’s theme, #AccelerateAction, underscores the urgency of progress. We are proud of the remarkable women on our team – their impact continues to inspire change.…

In honor of #EmployeeAppreciationDay, we express gratitude to our team for making our company a wonderful place to work. While our employees picked different words to describe their teams, we all agree that our colleagues and the culture we have built together are the keys to our…
Krishnan Viswanadhan, Pharm.D, joined us today as our new Chief Corporate Development and Strategy Officer. As a member of our Leadership Team, he will spearhead strategic planning and corporate development initiatives that drive continued growth for our company. With a…
#AgiosNews: Today, our Leadership Team attended the TD Cowen 45th Annual Healthcare Conference, sharing key insights on our 2025 strategic priorities and engaging with investors on our vision for the future.

#RareDiseaseDay comes once a year, but for those living with a rare disease, every day is an opportunity to raise awareness, offer support, and inspire hope. We stand with patients, caregivers and physicians – because together, we can do more. Join us in honoring this community,…
For our final Agios Association of Black Professionals (#AAoBP) spotlight this #BlackHistoryMonth, we celebrate Marley Abram, a dedicated Hemolytic Anemia Specialist. For Marley, this month is more than a time for reflection – it’s a call to action. While we honor the…
